Dr. Gerson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Ave
Burlington, VT 05401Phone+1 802-847-8400
Education & Training
- Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2012 - 2015
- Case Western Reserve University School of MedicineClass of 2012, MD
Certifications & Licensure
- CA State Medical License 2013 - Present
- NY State Medical License 2022 - 2026
- VT State Medical License 2022 - 2026
- PA State Medical License 2015 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 235 citationsPirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak, Chan Yoon Cheah, John M. Pagel
Lancet. 2021-03-06 - 65 citationsSurvival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era.James N. Gerson, Elizabeth Handorf, Diego Villa, Alina S. Gerrie, Parv Chapani
Journal of Clinical Oncology. 2019-01-07 - 57 citationsT cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.Guido Ghilardi, Joseph A Fraietta, James N Gerson, Vivianna M Van Deerlin, Jennifer J D Morrissette
Nature Medicine. 2024-04-01
Press Mentions
- UVM Cancer Center to Hold 26th Annual Women’s Health and Cancer Conference on Sept. 29September 27th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: